Climate Change Data

Environmental Metrics

ESG Focus Areas

• Sustainable Business
• Social problem solving
• Peace and Ethics
• Human Resources

Social Achievements

• Launched HAL for Well-being, supporting both caregivers and care receivers.
• Introduced Cyin for Living Support, aiding patients with communication and movement difficulties.
• Developed a new Cleaning Robot (CL02) incorporating AI and improved sensing.
• Established CEJ Fund to support venture companies contributing to society.

Governance Achievements

• Established Peace and Ethics Committee to prevent misuse of technology.
• Implemented measures to improve corporate governance, enhancing transparency and compliance.

Climate Goals & Targets

Environmental Challenges

• Operating in a novel business category with high uncertainty.
• Competition from other companies developing wearable robots.
• Dependence on a limited range of products (HAL).
• Securing regulatory approvals for medical devices in different countries.
• Securing insurance coverage for treatments using HAL.
• Risks associated with overseas business expansion.
• Potential for product malfunctions and liability claims.
• Risks related to intellectual property.
• Risks associated with the dual-class share structure.
• Continued operating losses and need for funding.

Mitigation Strategies

• Strategic alliances with insurance companies and technology firms.
• Focus on clinical trials and research to expand HAL's applications.
• Development of new products to diversify revenue streams.
• Proactive risk management and internal control systems.
• Establishment of the Peace and Ethics Committee.
• Dual-class share structure to ensure peaceful use of technology.
• Seeking government subsidies and other funding sources.

Supply Chain Management

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

• SDG 3: Good Health and Well-being
• SDG 9: Industry, Innovation and Infrastructure
• SDG 16: Peace, Justice and Strong Institutions

The company's products and initiatives contribute to these goals by improving healthcare, fostering innovation, and promoting ethical business practices.

Sustainable Products & Innovation

• Medical HAL
• HAL for Well-being
• HAL Lumbar Type for Care/Labor Support
• Cyin for Living Support
• Cleaning Robot CL02

Environmental Metrics

ESG Focus Areas

• Sustainable Business
• Social problem solving
• Peace and Ethics
• Human Resources

Environmental Achievements

• Deployed HAL Lumbar Type for Labor Support to assist volunteer workers in disaster sites, preventing economic class syndromes in emergency shelters.

Social Achievements

• Launched Neuro HALFIT program at 12 Robocare Centers in Japan, improving physical function for those with weakened bodily functions and disabilities.
• Expanded HAL FIT training program with AIG Japan Holdings Kabushiki Kaisha, providing training to more students with disabilities.
• Established business alliances with insurance companies (AIG and Sompo Japan) to increase access to HAL FIT program.
• Established CEJ Fund to support venture companies in medicine, AI, and Big Data.

Governance Achievements

• Established Peace and Ethics Committee to prevent misuse of advanced technologies for harmful purposes.
• Implemented robust corporate governance measures, including a Board of Directors and Audit and Supervisory Board with a significant number of independent members.
• Established systems to ensure the appropriateness of business operations and compliance.

Climate Goals & Targets

Environmental Challenges

• High uncertainty in a novel business category.
• Competition from other companies developing wearable robots.
• Dependence on a limited range of products (HAL).
• Challenges in obtaining medical device approvals in different countries.
• Securing insurance coverage for Cybernic Treatment.
• Risks associated with business alliances and acquisitions.
• Risks associated with overseas business operations.
• Potential for product malfunctions and liability claims.
• Risks related to intellectual property.
• Risks associated with the President's concurrent position as a university professor.
• Risks associated with development businesses in general.
• Risks associated with the dual class share structure.
• Continued operating losses and need for funding.
• Fluctuations in foreign exchange rates.

Mitigation Strategies

• Continuous research and development of new products.
• Focus on differentiation through unique Cybernic voluntary control technology.
• Intellectual property protection through patents and exclusive licenses.
• Proactive measures to obtain medical device approvals and insurance coverage.
• Careful evaluation of alliances and acquisitions.
• Risk management system and internal audits.
• Measures to avoid conflicts of interest between the company and the University of Tsukuba.
• Product liability insurance.
• Continuous technical investigations to avoid intellectual property infringement.
• Legal advice and guidance from TMI Associates.
• Strengthening financial base through governmental subsidies and other means.

Supply Chain Management

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

• SDG 3: Good Health and Well-being
• SDG 9: Industry, Innovation and Infrastructure
• SDG 16: Peace, Justice and Strong Institutions

The Group's products and activities contribute to these goals by improving healthcare, fostering innovation, and promoting ethical business practices.

Sustainable Products & Innovation

• HAL
• Cyin
• VS-AS01
• Cleaning Robot CL02

Environmental Metrics

ESG Focus Areas

• Health
• Sustainability
• Innovation
• Social Inclusion
• Global Collaboration

Environmental Achievements

• Not disclosed

Social Achievements

• Expanded Neuro HALFIT program to 17 locations nationwide in Japan; Increased HAL rentals in Malaysia through partnership with SOCSO; Launched patient information magazine and website for neuromuscular diseases; Partnered with various insurance companies to cover Neuro HALFIT costs.
• Established Cybernics Medical Innovation Base to promote collaboration in medical and biotechnology fields.

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Upfront investment in new businesses through acquired subsidiaries; Temporary delay in HAL introduction to Japanese hospitals due to COVID-19; Increased SG&A expenses due to M&A.

Mitigation Strategies

• Progress in US medical, healthcare, and welfare services; Continued expansion of HAL rentals to Europe and Asia; Medical device approval and insurance listing of stroke and spinal cord injury in Japan; Expansion of cleaning/disinfection robot CL02, Vital Sensor “Cyvis”, and commercialization of photoacoustic imaging device “Acoustic X”.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: IFRS

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• SDG 3 (Good Health and Well-being)
• SDG 9 (Industry, Innovation, and Infrastructure)
• SDG 10 (Reduced Inequalities)
• SDG 11 (Sustainable Cities and Communities)

Cyberdyne's initiatives contribute to these SDGs through the development and deployment of Cybernics technology to improve health outcomes, promote sustainable industrialization, reduce inequalities, and create sustainable cities.

Sustainable Products & Innovation

• Wearable Cyborg HAL, Cyvis vital sensor, photoacoustic imaging device

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Health Risk Management
• Social Inclusion
• Sustainable Industrialization
• Society 5.0/5.1 Realization

Environmental Achievements

• Not disclosed

Social Achievements

• Disseminated Cybernics Treatment globally, improving functional regeneration.
• Expanded Neuro HALFIT program to 17 locations nationwide.
• Developed Cyin for Living Support to aid severely disabled communication.
• Developed HAL Lumbar Type to support workers in heavy labor, reducing back pain risk.
• Established C-Startup, an innovation ecosystem supporting over 30 startups with over 10 billion yen investment.

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Expansion of operating loss due to initial costs of acquired subsidiaries and impairment loss of goodwill.

Mitigation Strategies

• Cost reduction strategies for C2 Inc. and LeyLine GmbH to achieve profitability.
• Optimization of labor costs in RISE Healthcare Group.
• Expansion of product rental and treatment services.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• SDG 3 (Good Health and Well-being)
• SDG 9 (Industry, Innovation, and Infrastructure)
• SDG 10 (Reduced Inequalities)
• SDG 11 (Sustainable Cities and Communities)

Cyberdyne's technologies and initiatives contribute to these goals through improved healthcare, technological innovation, social inclusion, and sustainable city development.

Sustainable Products & Innovation

• Wearable Cyborg HAL, Cyvis vital sensor, Acoustic X imaging device, CL02 cleaning robot

Awards & Recognition

• Not disclosed